Black Friday Get Elite for just $149.00 Claim Now

X4 Pharmaceuticals, Inc.

Contributing Author

Recent Articles by X4 Pharmaceuticals, Inc.

Feb-27

X4 Pharmaceuticals Receives Positive Opinion from the EMA CHMP Recommending Approval of Mavorixafor in the EU for WHIM Syndrome XFOR +5.85% GlobeNewswire

Affiliate • Advertise • APIs • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Stock quotes delayed by 1 minute. Futures and options delayed by 15 minutes.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)